Statistical models for heart rate correction of the QT interval-Reference-Cited by-同舟云学术

Statistical models for heart rate correction of the QT interval

Published:2010-03-08 Issue:7-8 Volume:29 Page:786-796
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statist. Med.

Author:

Ring Arne

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/sim.3791/fullpdf

Reference36 articles.

1. Clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs: guidance to industry;Federal Register,2005

2. Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei Herzkranken. Teil I: Beziehung zwischen der Pulsfrequenz und der Dauer des Ventrikelelektrokardiogramms bei normalen Menschen in der Ruhe;Fridericia;Acta Medica Scandinavica,1920

3. An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study);Sagie;American Journal of Cardiology,1992

4. An exponential formula for heart rate dependence of QT interval during exercise and cardiac pacing in humans: reevaluation of Bazett's formula;Sarma;American Journal of Cardiology,1984

5. QT-RR relationship in healthy subjects exhibits substantial intersubject variability and high intrasubject stability;Batchvarov;American Journal of Physiology, Heart and Circulatory Physiology,2002

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A tutorial on model informed approaches to cardiovascular safety with focus on cardiac repolarisation;Journal of Pharmacokinetics and Pharmacodynamics;2018-05-07

2. Cardiovascular toxicity, especially QT/QTc prolongation;Statistical Methods for Evaluating Safety in Medical Product Development;2014-12-12

3. Dabigatran Does Not Prolong the QT Interval with Supratherapeutic Exposure: a Thorough QT Study in Healthy Subjects;Clinical Drug Investigation;2013-03-22

4. Validation of QT Interval Correction Methods When a Drug Changes Heart Rate;Therapeutic Innovation & Regulatory Science;2013-03

5. The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) study;Cardiovascular Diabetology;2013